Comparison of the Long-Term Risk of Recurrence and Other Clinical Outcomes in GIST Patients Receiving Imatinib as Adjuvant Therapy—A Retrospective Chart Extract-Based Approach

PURPOSE: To compare characteristics of patients, the risk of recurrence, and mortality among adult patients with primary resectable gastrointestinal stromal tumor (GIST) receiving short-term (6–12 months) versus long-term (≥ 24 months) imatinib therapy. METHODS: Detailed information on primary resec...

Descripción completa

Detalles Bibliográficos
Autores principales: Conley, Anthony Paul, Guérin, Annie, Sasane, Medha, Gauthier, Geneviève, Schwiep, Frances, Keir, Christopher Hunt, Wu, Eric Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636436/
https://www.ncbi.nlm.nih.gov/pubmed/23229801
http://dx.doi.org/10.1007/s12029-012-9467-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636436/
https://www.ncbi.nlm.nih.gov/pubmed/23229801
http://dx.doi.org/10.1007/s12029-012-9467-1

Ejemplares similares